Optic disc topographic analysis in diabetic patients
The aim of our study was to evaluate the optic disc (OD) topographic parameters by using Heidelberg Retina Tomograph II (HRT II) in patients with type 2 diabetes mellitus (DM). The study group consisted of 78 patients with type 2 DM (patient group) and age-sex matched 50 healthy subjects (control group). All patients and controls underwent a detailed ophthalmological examination, automated perimetry, central corneal thickness (CCT) measurement and OD topography by using HRT II. Glycosylated haemoglobin (HbA1c) levels of the diabetic patients were also noted. Age, gender, intraocular pressure and CCT measurements were similar in patients with diabetes and control group. Mean retinal nerve fiber layer thickness (MRNFLT) and retinal nerve fiber layer cross-sectional area (RNFLcsA) parameters were found significantly lower in diabetic patients compared to those of the controls (p = 0.030, p = 0.038). In the patient group, MRNFLT value was found significantly lower in patients with DM duration ≥120 months (p = 0.020) and HbA1c level ≥7 % (p = 0.029). Rim volume, MRNFLT and RNFLcsA values were significantly lower in proliferative diabetic retinopathy group (p = 0.004, p = 0.003, p = 0.001 respectively) and laser treated patients (p = 0.003, p = 0.002, p = 0.004 respectively). In conclusion, poor metabolic control of diabetes, severe DR and received laser therapies cause RNFL damage. Heidelberg Retina Tomograph may help us to detect and follow-up the changes in optic disc and RNFL in diabetic patients.
KeywordsDiabetes mellitus Heidelberg Retina Tomograph Retinal nerve fiber layer thickness Optic disc topography Glycosylated haemoglobin
This study was presented orally at 44th National Congress of Turkish Ophthalmology Society (29th September–3rd October 2010 Antalya-TURKEY).
- 2.Adler AI, Stratton IM, Neil HA, Yudkin JS, Matthews DR, Cull CA, Wright AD, Turner RC, Holman RR (2000) Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ 321:412–419PubMedCrossRefGoogle Scholar
- 5.Zangwill LM, Weinreb RN, Berry CC, Smith AR, Dirkes KA, Liebmann JM, Brandt JD, Trick G, Cioffi GA, Coleman AL, Piltz-Seymour JR, Gordon MO, Kass MA (2004) The confocal scanning laser ophthalmoscopy ancillary study to the ocular hypertension treatment study: study design and baseline factors. Am J Ophthalmol 137:219–227PubMedCrossRefGoogle Scholar
- 10.Van Dijk HW, Verbraak FD, Kok PH, Stehouwer M, Garvin MK, Sonka M, Devries JH, Schlingemann RO, Abramoff MD (2012) Early neurodegeneration in the retina of type 2 diabetic patients. Invest Ophthalmol Vis Sci [Epub ahead of print]Google Scholar
- 12.Chihara E, Zhang S (1998) Analysis of diabetic optic neuropathy with a topographic laser scanning system. Nippon Ganka Gakkas Zasshi 102:431–435Google Scholar
- 20.Sugimoto M, Sasoh M, Ido M, Narushima C, Uji Y (2010) Retinal nerve fiber layer decrease during glycemic control in type 2 diabetes. J Ophthalmol. doi: 10.1155/2010/569215